101 related articles for article (PubMed ID: 10556832)
1. Elastase and metalloproteinase activities regulate soluble complement receptor 1 release.
Sadallah S; Hess C; Miot S; Spertini O; Lutz H; Schifferli JA
Eur J Immunol; 1999 Nov; 29(11):3754-61. PubMed ID: 10556832
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch.
Tosi MF; Zakem H; Berger M
J Clin Invest; 1990 Jul; 86(1):300-8. PubMed ID: 2164045
[TBL] [Abstract][Full Text] [Related]
3. Cleavage of membrane-bound C3b and C3bi by viable human neutrophils (PMN).
Gaither TA; Hammer CH; Gadek JE; Katusha K; Santaella M; Frank MM
Mol Immunol; 1983 Jun; 20(6):623-35. PubMed ID: 6603572
[TBL] [Abstract][Full Text] [Related]
4. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage.
Danielsson C; Pascual M; French L; Steiger G; Schifferli JA
Eur J Immunol; 1994 Nov; 24(11):2725-31. PubMed ID: 7957565
[TBL] [Abstract][Full Text] [Related]
5. Modulation of neutrophil expression of C3b receptors (CR1) by soluble monomeric human C3b.
Porteu F; Mir A; Halbwachs-Mecarelli L
Eur J Immunol; 1987 May; 17(5):629-35. PubMed ID: 2953614
[TBL] [Abstract][Full Text] [Related]
6. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis.
Berger M; Sorensen RU; Tosi MF; Dearborn DG; Döring G
J Clin Invest; 1989 Oct; 84(4):1302-13. PubMed ID: 2507578
[TBL] [Abstract][Full Text] [Related]
7. The interaction of small oligomers of complement 3B (C3B) with phagocytes. High affinity binding and phorbol ester-induced internalization by polymorphonuclear leukocytes.
Brown EJ
J Biol Chem; 1989 Apr; 264(11):6196-201. PubMed ID: 2649497
[TBL] [Abstract][Full Text] [Related]
8. Cleavage of membrane bound C3bi, an intermediate of the third component of complement, to C3c and C3d-like fragments by crude leucocyte lysosomal lysates and purified leucocyte elastase.
Carlo JR; Spitznagel JK; Studer EJ; Conrad DH; Ruddy S
Immunology; 1981 Oct; 44(2):381-91. PubMed ID: 7028603
[TBL] [Abstract][Full Text] [Related]
9. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
[TBL] [Abstract][Full Text] [Related]
10. Soluble complement receptor type 1 (CD35) in bronchoalveolar lavage of inflammatory lung diseases.
Hamacher J; Sadallah S; Schifferli JA; Villard J; Nicod LP
Eur Respir J; 1998 Jan; 11(1):112-9. PubMed ID: 9543279
[TBL] [Abstract][Full Text] [Related]
11. Interaction of human monomeric C3b with its receptor (complement receptor type 1, CR1) on neutrophils. Evidence for negative cooperativity.
Porteu F; Halbwachs-Mecarelli L
J Biol Chem; 1988 Apr; 263(11):5091-7. PubMed ID: 2965698
[TBL] [Abstract][Full Text] [Related]
12. Intracellular degradation of the complement C3b/C4b receptor in the absence of ligand.
Turner JR; Tartakoff AM; Berger M
J Biol Chem; 1988 Apr; 263(10):4914-20. PubMed ID: 2965151
[TBL] [Abstract][Full Text] [Related]
13. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
Paccaud JP; Carpentier JL; Schifferli JA
Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
[TBL] [Abstract][Full Text] [Related]
14. Proteases produced by activated neutrophils are able to release soluble CD23 fragments endowed with proinflammatory effects.
Brignone C; Munoz O; Batoz M; Rouquette-Jazdanian A; Cousin JL
FASEB J; 2001 Sep; 15(11):2027-9. PubMed ID: 11511513
[TBL] [Abstract][Full Text] [Related]
15. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen.
Wright SD; Weitz JI; Huang AJ; Levin SM; Silverstein SC; Loike JD
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7734-8. PubMed ID: 2971974
[TBL] [Abstract][Full Text] [Related]
16. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
Forslid J; Hed J; Stendahl O
Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte elastase and cathepsin G are specific inhibitors of C5a-dependent neutrophil enzyme release and chemotaxis.
Tralau T; Meyer-Hoffert U; Schröder JM; Wiedow O
Exp Dermatol; 2004 May; 13(5):316-25. PubMed ID: 15140022
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of neutrophil elastase by alpha1-protease inhibitor at the surface of human polymorphonuclear neutrophils.
Korkmaz B; Attucci S; Jourdan ML; Juliano L; Gauthier F
J Immunol; 2005 Sep; 175(5):3329-38. PubMed ID: 16116225
[TBL] [Abstract][Full Text] [Related]
19. CR1, CD35 in synovial fluid from patients with inflammatory joint diseases.
Sadallah S; Lach E; Lutz HU; Schwarz S; Guerne PA; Schifferli JA
Arthritis Rheum; 1997 Mar; 40(3):520-6. PubMed ID: 9082940
[TBL] [Abstract][Full Text] [Related]
20. Human neutrophil elastase releases a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. Comparison with the proteolytic activity responsible for shedding of TNF receptors from stimulated neutrophils.
Porteu F; Brockhaus M; Wallach D; Engelmann H; Nathan CF
J Biol Chem; 1991 Oct; 266(28):18846-53. PubMed ID: 1655765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
